** Shares of DNA testing firm 23andMe ME.O fall 31.4% to $2.2 premarket
** ME's CEO Anne Wojcicki offers to buy the remaining stake in the company for $0.41/shr, or about $11 mln
** Wojcicki says private equity firm New Mountain is no longer interested in acquiring ME
** Last month, Wojcicki and New Mountain Capital had offered to take the company private for $2.53 per share, valuing the company at $67.9 million
** Stock has fallen 82% in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.